Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corp (NQ: TWST )

41.05 +2.94 (+7.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,575,318
Open 38.69
Bid (Size) 38.80 (3)
Ask (Size) 41.33 (1)
Prev. Close 38.11
Today's Range 38.01 - 41.30
52wk Range 25.07 - 139.99
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Twist Bioscience to Present at Fujifilm’s 12th Annual Global IT Executive Summit
From Twist Bioscience Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-50.70%
-50.70%
1 Month
+16.72%
+16.72%
3 Month
-9.60%
-9.60%
6 Month
-48.86%
-48.86%
1 Year
-66.50%
-66.50%

More News

Read More
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at Upcoming Investor Conferences
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Via Benzinga
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Reports Second Quarter 2022 Financial Results
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Twist Bioscience Highlights Synthetic Libraries and High Throughput Antibody Discovery Platform at PEGS Boston 2022
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Launches High Throughput Antibody Production Platform
From Twist Bioscience Corporation
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Twist Bioscience to Become Voting Member of Storage Networking Industry Association
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience Announces Promotions and Changes to Executive Leadership Team
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience to Report Fiscal 2022 Second Quarter Financial Results on Thursday, May 5, 2022
From Twist Bioscience Corporation
Via Business Wire
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
Via InvestorPlace
Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics
Via Benzinga
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
From Twist Bioscience Corporation
Via Business Wire
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
DNA Data Storage Alliance Welcomes 50th Member
From DNA Data Storage Alliance
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.